Cancer screening: the tests that actually save lives
Age- and risk-based screening for a handful of cancers — colorectal, breast, cervical, lung — where catching it early genuinely changes the outcome.
The quick answer
A small set of screening tests has strong evidence behind it — start colorectal screening at 45, keep up with cervical and breast screening on schedule, and add lung screening if you have a heavy smoking history. Follow the established guidelines rather than chasing whole-body scans, which mostly find things that scare you without helping you.
Screening is the part of preventive medicine with the least glamour and some of the best returns — when it’s aimed correctly. The whole idea rests on a simple premise: for a few specific cancers, catching disease early, before symptoms, meaningfully changes whether you survive it. For those cancers, screening is one of the highest-value things in this entire guide. The catch is that the premise only holds for some cancers, at some ages, and screening the wrong thing does real harm.
The short list that earns it
Major guideline bodies converge on a compact set. Colorectal screening now starts at 45 for average-risk adults and runs to 75 — colonoscopy, stool-based tests (FIT, multi-target stool DNA), and CT colonography are all legitimate, and the best test is largely the one you’ll actually do. Cervical screening (Pap and/or HPV testing) has quietly turned a common cancer into a rare one in screened populations. Breast screening with mammography reduces breast-cancer death, with the exact start age and interval a genuine judgment call to make with a clinician. Lung screening with low-dose CT is high-value but only for people with a significant smoking history — it’s targeted, not universal.
Why more isn’t better
Screening is not free, and its costs aren’t just money. Every test has a false-positive rate that generates anxiety, follow-up procedures, and occasional complications. Worse, some screening finds cancers that would never have harmed you — overdiagnosis — and then treats them anyway, with real side effects. This is why serious screening is rationed by age and risk: the benefit only outweighs the harm inside specific windows.
It’s also why the “whole-body MRI” and “scan everything” pitches deserve skepticism. Marketed as thoroughness, they mostly generate incidental findings — the harmless cyst, the nodule of no consequence — that lead to more scans, biopsies, and worry without extending anyone’s life. Comprehensiveness in a guide like this one does not mean screening for everything; it means knowing which few tests have the evidence and doing those well.
The practical version
Know your age-appropriate list, know your family history (which can move some tests earlier or add others), and keep to the schedule. That’s the boring, evidence-based version — and it belongs in the labs tier because, like every test here, its value is only realized when the result leads to action.
Evidence, by outcome
Each claim carries its own grade. A strong grade on one outcome doesn't launder a weak one — read them separately.
The USPSTF recommends colorectal cancer screening for average-risk adults starting at age 45, a task the evidence supports as reducing colorectal cancer death. 1
Grade B recommendation; the starting age was lowered from 50 to 45 in 2021 as incidence rose in younger adults. Colonoscopy, stool tests, and CT colonography are all acceptable options.
Screening carries real harms — false positives, overdiagnosis, and overtreatment — which is why it's targeted by age and risk rather than applied to everyone for everything. 1
The reason 'more screening' is not automatically better. Whole-body MRI and unfocused panels are the cautionary end of this.
Sources
- 1 Guideline / consensus
Final Recommendation Statement: Screening for Colorectal Cancer (2021)
U.S. Preventive Services Task Force
Read the source uspreventiveservicestaskforce.org